FDA Investigator

Deepa E Vadakkan

Latest inspection on record: Las Cruces, United States, May 2026 · records back to 2024

Biologics

FDA inspection record · Last updated July 12, 2026

Overview

  • 21 inspections across 21 sites are on record.
  • 17 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-05-20.

At a glance

Inspections

21

Sites

21

Observations

17

Career since

Sep 2024

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
PHC- Las Cruces, Inc.20 May 2026Biologics
KEDPLASMA LLC15 May 2026Biologics
KEDPLASMA LLC12 May 2026Biologics
Intermountain Health Lutheran Hospital28 Apr 2026BiologicsOn file
Medical Center of the Rockies10 Apr 2026Biologics

Sites inspected

PHC- Las Cruces, Inc.Las Cruces, United States1 insp.
KEDPLASMA LLCEl Paso, United States1 insp.
KEDPLASMA LLCEl Paso, United States1 insp.
Intermountain Health Lutheran HospitalWheat Ridge, United States1 insp.
Medical Center of the RockiesLoveland, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Full investigator report

Get the verbatim findings behind Deepa E Vadakkan's 17 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site